T. Rowe Price Associates’s Absci ABSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
1,489,993
+1,372,430
+1,167% +$7.73M ﹤0.01% 1188
2026
Q1
$353K Sell
117,563
-2,038,504
-95% -$5.9M ﹤0.01% 2605
2025
Q4
$7.53M Buy
2,156,067
+2,085,501
+2,955% +$7.6M ﹤0.01% 1294
2025
Q3
$215K Buy
70,566
+15,863
+29% +$43.9K ﹤0.01% 2764
2025
Q2
$141K Buy
54,703
+19,710
+56% +$55.5K ﹤0.01% 2816
2025
Q1
$88K Buy
34,993
+5,660
+19% +$20.8K ﹤0.01% 2847
2024
Q4
$77K Buy
29,333
+3,747
+15% +$13.2K ﹤0.01% 2879
2024
Q3
$98K Hold
25,586
﹤0.01% 2823
2024
Q2
$0 Buy
+25,586
New +$119K ﹤0.01% 2920

Other funds holding ABSI

T. Rowe Price Associates's ABSI Position: Q2 2026 in Review

T. Rowe Price Associates increased its Absci (ABSI) stake by 1,167% in Q2 2026, buying an estimated $7.73M and bringing the position to 1,489,993 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

T. Rowe Price Associates first reported a position in ABSI in Q2 2024 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

  • T. Rowe Price Associates held 1,489,993 shares of Absci worth $17.3M as of Q2 2026.
  • T. Rowe Price Associates bought 1,372,430 Absci shares in Q2 2026, an estimated $7.73M.
  • Absci made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1188 holding.
  • T. Rowe Price Associates first reported a position in Absci in Q2 2024 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.